These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45 related articles for article (PubMed ID: 15602166)
1. Inpatient Cost Burdens of Treating Chronic Hepatitis B in US Hospitals: A Weighted Analysis of a National Database. Lee DU; Bhowmick K; Kolachana S; Schuster K; Bahadur A; Harmacinski A; Schellhammer S; Fan GH; Lee KJ; Sun C; Chou H; Lominadze Z Dig Dis Sci; 2024 Jul; 69(7):2401-2429. PubMed ID: 38658506 [TBL] [Abstract][Full Text] [Related]
2. Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysis. Schattenberg JM; Lazarus JV; Newsome PN; Serfaty L; Aghemo A; Augustin S; Tsochatzis E; de Ledinghen V; Bugianesi E; Romero-Gomez M; Bantel H; Ryder SD; Boursier J; Leroy V; Crespo J; Castera L; Floros L; Atella V; Mestre-Ferrandiz J; Elliott R; Kautz A; Morgan A; Hartmanis S; Vasudevan S; Pezzullo L; Trylesinski A; Cure S; Higgins V; Ratziu V Liver Int; 2021 Jun; 41(6):1227-1242. PubMed ID: 33590598 [TBL] [Abstract][Full Text] [Related]
3. Identification of hepatitis B and C screening and patient management guidelines and availability of training for chronic viral hepatitis among health professionals in six European countries: results of a semi-quantitative survey. Bechini A; Falla A; Ahmad A; Veldhuijzen I; Boccalini S; Porchia B; Levi M BMC Infect Dis; 2015 Aug; 15():353. PubMed ID: 26286525 [TBL] [Abstract][Full Text] [Related]
4. Hemodialysis patients and complications management costs in Italy: Plastic cannulae a potentially cost-effective strategy. Tito F; Davidson-Peck D; Roettger AD; Borghetti F; Corbo M; Tozzi M J Vasc Access; 2024 Mar; 25(2):599-606. PubMed ID: 36250425 [TBL] [Abstract][Full Text] [Related]
5. Costs and where to find them: identifying unit costs for health economic evaluations of diabetes in France, Germany and Italy. Pöhlmann J; Norrbacka K; Boye KS; Valentine WJ; Sapin H Eur J Health Econ; 2020 Nov; 21(8):1179-1196. PubMed ID: 33025257 [TBL] [Abstract][Full Text] [Related]
6. Understanding Molecular Testing Uptake Across Tumor Types in Eight Countries: Results From a Multinational Cross-Sectional Survey. Chambers P; Man KKC; Lui VWY; Mpima S; Nasuti P; Forster MD; Wong ICK JCO Oncol Pract; 2020 Aug; 16(8):e770-e778. PubMed ID: 32160136 [TBL] [Abstract][Full Text] [Related]
7. The Incidence, Prevalence, and Mortality of Stroke in France, Germany, Italy, Spain, the UK, and the US: A Literature Review. Zhang Y; Chapman AM; Plested M; Jackson D; Purroy F Stroke Res Treat; 2012; 2012():436125. PubMed ID: 22550614 [TBL] [Abstract][Full Text] [Related]
8. A Quantitative Analysis of Cold Water for Human Consumption in Hospitals in Spain. González AG; García-Sanz-Calcedo J; Salgado DR; Mena A J Healthc Eng; 2016; 2016():. PubMed ID: 27372383 [TBL] [Abstract][Full Text] [Related]
9. Corrigendum to "Treatment patterns in essential tremor: Real-world evidence from a United Kingdom and France primary care database". Eur J Neurol; 2024 Jun; 31(6):e16218. PubMed ID: 38323689 [No Abstract] [Full Text] [Related]
10. Reprotech in France and the United States: Differences and similarities - An introduction. Mathieu S; Rapp R Reprod Biomed Soc Online; 2020 Nov; 11():106-109. PubMed ID: 33817356 [No Abstract] [Full Text] [Related]
11. An economic evaluation of contingency management for completion of hepatitis B vaccination in those on treatment for opiate dependence. Rafia R; Dodd PJ; Brennan A; Meier PS; Hope VD; Ncube F; Byford S; Tie H; Metrebian N; Hellier J; Weaver T; Strang J Addiction; 2016 Sep; 111(9):1616-27. PubMed ID: 26990598 [TBL] [Abstract][Full Text] [Related]
12. Health related management plans improve sleep disorders of patients with chronic liver disease. Liu C; Xie H; Zhang X; Yu Y; Zhang X; Sun Y; Zhou L; Su B; Wang H Int J Clin Exp Med; 2015; 8(6):9883-9. PubMed ID: 26309672 [TBL] [Abstract][Full Text] [Related]
13. Update on the management of cirrhosis - focus on cost-effective preventative strategies. Neff GW; Kemmer N; Duncan C; Alsina A Clinicoecon Outcomes Res; 2013; 5():143-52. PubMed ID: 23626470 [TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of first-line oral antiviral therapies for chronic hepatitis B : a systematic review. Buti M; Oyagüez I; Lozano V; Casado MA Pharmacoeconomics; 2013 Jan; 31(1):63-75. PubMed ID: 23329593 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis B management costs in France, Italy, Spain, and the United Kingdom. Brown RE; De Cock E; Colin X; Antoñanzas F; Iloeje UH J Clin Gastroenterol; 2004; 38(10 Suppl 3):S169-74. PubMed ID: 15602166 [TBL] [Abstract][Full Text] [Related]
16. Healthcare resource utilization and costs by disease severity in an insured national sample of US patients with chronic hepatitis B. Nguyen MH; Burak Ozbay A; Liou I; Meyer N; Gordon SC; Dusheiko G; Lim JK J Hepatol; 2019 Jan; 70(1):24-32. PubMed ID: 30287341 [TBL] [Abstract][Full Text] [Related]
17. Cost of chronic hepatitis B infection in the United States. Lee TA; Veenstra DL; Iloeje UH; Sullivan SD J Clin Gastroenterol; 2004; 38(10 Suppl 3):S144-7. PubMed ID: 15602162 [TBL] [Abstract][Full Text] [Related]
18. The direct cost of managing patients with chronic hepatitis B infection in Australia. Butler JR; Pianko S; Korda RJ; Nguyen S; Gow PJ; Roberts SK; Strasser SI; Sievert W J Clin Gastroenterol; 2004; 38(10 Suppl 3):S187-92. PubMed ID: 15602169 [TBL] [Abstract][Full Text] [Related]
19. [Direct and indirect costs associated with respiratory allergic diseases in Italy. A probabilistic cost of illness study]. Marcellusi A; Viti R; Incorvaia C; Mennini FS Recenti Prog Med; 2015 Oct; 106(10):517-27. PubMed ID: 26442978 [TBL] [Abstract][Full Text] [Related]